Article
Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
The Journal of biological chemistry - 25 Feb 2005
Lu Meiling, Kwan Toni, Yu Chunjiang, Chen Feng, Freedman Bethany, Schafer Jennifer M, Lee Eun-Jig, Jameson J Larry, Jordan V Craig, Cryns Vincent L
Abstract excerpt
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising cancer therapy that preferentially induces apoptosis in cancer cells. However, many neoplasms are resistant to TRAIL by mechanisms that are poorly understood. Here we demonstrate that human breast cancer cells, but not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
